Aclaris Therapeutics's total assets for Q1 2025 were $198.09M, a decrease of -10.09% from the previous quarter. ACRS total liabilities were $54.03M for the fiscal quarter, a -16.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.